A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma (Q30427677)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma |
scientific article |
Statements
1 reference
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma (English)
1 reference
David A Reardon
1 reference
Patrick Y Wen
1 reference
Timothy F Cloughesy
1 reference
David Schiff
1 reference
Jeffrey J Raizer
1 reference
John Laterra
1 reference
Melanie Smitt
1 reference
Michael Wolf
1 reference
Kelly S Oliner
1 reference
Abraham Anderson
1 reference
Min Zhu
1 reference
Elwyn Loh
1 reference
4 February 2011
1 reference
1 reference
437-446
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference